FDA proposes standards for cord blood banks to sell stem cells

01/16/2007 | Reuters

The FDA has proposed that umbilical cord blood banks would not have to conduct clinical trials on use of the blood stem cells they intend to sell. Instead, the agency proposed requiring the banks to submit research already available on the use in getting approval to sell stem cells.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC